Factors | Univariate analysis OS | Multivariate analysis OS | ||
---|---|---|---|---|
HR (95%CI) | P value | HR (95%CI) | P value | |
Age | Â | Â | Â | Â |
 < 65 |  |  |  |  |
 ≥ 65 | 1.861 (1.009–3.432) | 0.047 | 2.286 (1.215–4.303) | 0.010 |
Gender | Â | Â | Â | Â |
 Male |  |  |  |  |
 Female | 0.634 (0.340–1.181) | 0.151 |  |  |
Hemorrhage | Â | Â | Â | Â |
 No |  |  |  |  |
 Yes | 0.938 (0.480–1.832) | 0.851 |  |  |
Rupture | Â | Â | Â | Â |
 No |  |  |  |  |
 Yes | 1.987 (0.479–8.241) | 0.344 |  |  |
Resection style | Â | Â | Â | Â |
 Complete resection |  |  |  |  |
 Incomplete resection | 9.217 (4.471–19.003) | < 0.001 | 5.546 (2.558–12.024) | < 0.001 |
Tumor site | Â | Â | Â | Â |
 Stomach |  |  |  |  |
 Non-stomach | 3.532 (1.893–6.589) | < 0.001 | 2.115 (1.092–4.096) | 0.026 |
Tumor size | Â | Â | Â | Â |
 < 5 cm |  |  |  |  |
 ≥ 5 cm | 3.393 (1.702–6.764) | 0.001 | 0.987 (0.414–2.356) | 0.977 |
Mitotic index | Â | Â | Â | Â |
 < 5/HPF |  |  |  |  |
 ≥ 5/HPF | 2.168 (1.183–3.974) | 0.012 | 0.797 (0.397–1.602) | 0.524 |
NIH risk grade | Â | Â | Â | Â |
 Extremely low or low |  |  |  |  |
 Moderate or high | 6.220 (2.441–15.847) | < 0.001 | 4.289 (1.623–11.332) | 0.003 |
c-kit exons | Â | Â | Â | Â |
 Negative |  |  |  |  |
 Positive | 1.208 (0.650–2.246) | 0.550 |  |  |
PDGFRA exons | Â | Â | Â | Â |
 Negative |  |  |  |  |
 Positive | 1.355 (0.483–3.797) | 0.564 |  |  |
Preoperative CA125 level | Â | Â | Â | Â |
 Normal |  |  |  |  |
 High | 2.812 (1.382–5.723) | 0.004 | 0.894 (0.292–2.737) | 0.844 |
Increased CA125 level both preoperative and postoperative | Â | Â | Â | Â |
 No |  |  |  |  |
 Yes | 5.560 (2.341–13.204) | < 0.001 | 2.293 (0.931–5.651) | 0.071 |